Peptidylarginine deiminase (PAD) inhibitors
US8404647B2 · kind B2 · utility
0Cited by
1References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 10, 2010 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Dec 10, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to PAD inhibitors that are suitable to be used as a medicament against an autoimmune disease such as RA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.